NQO1 609C>T polymorphism interaction with tobacco smoking and alcohol drinking increases colorectal cancer risk in a Chinese population

Gene

Volumn 521, Issue 1, 2013, Pages 105-110

  Peng, Xian E ^a   Jiang, Ying Ying ^a   Shi, Xi Shun ^a   Hu, Zhi Jian ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Gene environment interaction; NQO1; Polymorphism

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; DRINKING BEHAVIOR; ENVIRONMENTAL FACTOR; FEMALE; FOOD INTAKE; FRUIT; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TEA; VEGETABLE;

ADULT; AGED; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIET; FEMALE; FRUIT; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; VEGETABLES;

NICOTIANA TABACUM;

EID: 84876739380     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.029     Document Type: Article

References (45)

1. Ahmed F.E. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2004, 22:91-147.
2. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 1995, 49:127-140.
3. Center M.M., Jemal A., Smith R.A., Ward E. Worldwide variations in colorectal cancer. CA Cancer J. Clin. 2009, 59:366-378.
4. Cleary S.P., Cotterchio M., Shi E., Gallinger S., Harper P. Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am. J. Epidemiol. 2010, 172:1000-1014.
5. Ding R., Lin S., Chen D. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. Int. J. Colorectal. Dis. 2012, 27:885-892.
6. Dinkova-Kostova A.T., Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch. Biochem. Biophys. 2010, 501:116-123.
7. Fedirko V., et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 2011, 22:1958-1972.
8. Gao Y., Cao Y., Tan A., Liao C., Mo Z., Gao F. Glutathione S-transferase M1 polymorphism and sporadic colorectal cancer risk: an updating meta-analysis and HuGE review of 36 case-control studies. Ann. Epidemiol. 2010, 20:108-121.
9. Gasdaska P.Y., Powis G., Hyman P., Fisher H. Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma. Cancer Res. 1993, 53:5458-5461.
10. Hlavata I., et al. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol. Rep. 2010, 24:1347-1353.
11. Hosmer D.W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992, 3:452-456.
12. Hou L., et al. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 2005, 26:1122-1128.
13. Ingelman-Sundberg M., et al. Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 1993, 10:447-452.
14. Kim J., et al. Dietary intake of folate and alcohol, MTHFR C677T polymorphism, and colorectal cancer risk in Korea. Am. J. Clin. Nutr. 2012, 95:405-412.
15. Kono S. Lifestyle and environmental factors for colorectal cancer. Nihon Rinsho 2011, 69(Suppl. 3):51-54.
16. Lafuente M.J., et al. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis 2000, 21:1813-1819.
17. Leufkens A.M., et al. Cigarette smoking and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study. Clin. Gastroenterol. Hepatol. 2011, 9:137-144.
18. Long D.J., Waikel R.L., Wang X.J., Perlaky L., Roop D.R., Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res. 2000, 60:5913-5915.
19. Long D.J., Waikel R.L., Wang X.J., Roop D.R., Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J. Natl. Cancer Inst. 2001, 93:1166-1170.
20. Misra V., Klamut H.J., Rauth A.M. Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609. Br. J. Cancer 1998, 77:1236-1240.
21. Mitrou P.N., et al. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study. Carcinogenesis 2007, 28:875-882.
22. Moran J.L., Siegel D., Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8150-8155.
23. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 2000, 59:65-85.
24. Nebert D.W., Roe A.L., Vandale S.E., Bingham E., Oakley G.G. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet. Med. 2002, 4:62-70.
25. Nioi P., Hayes J.D. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat. Res. 2004, 555:149-171.
26. Nisa H., et al. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. BMC Cancer 2010, 10:274.
27. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
28. Ross D., Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 2004, 382:115-144.
29. Ross D., Siegel D., Beall H., Prakash A.S., Mulcahy R.T., Gibson N.W. DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev. 1993, 12:83-101.
30. Ross D., Kepa J.K., Winski S.L., Beall H.D., Anwar A., Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Interact. 2000, 129:77-97.
31. Sameer A.S., Shah Z.A., Syeed N., Rasool R., Afroze D., Siddiqi M.A. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac. J. Cancer Prev. 2010, 11:209-213.
32. Seitz H.K., Simanowski U.A., Homann N., Waldherr R. Cell proliferation and its evaluation in the colorectal mucosa: effect of ethanol. Z. Gastroenterol. 1998, 36:645-655.
33. Siegel D., McGuinness S.M., Winski S.L., Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 1999, 9:113-121.
34. Siegel D., et al. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol. Pharmacol. 2004, 65:1238-1247.
35. Tijhuis M.J., et al. NQO1 and NFE2L2 polymorphisms, fruit and vegetable intake and smoking and the risk of colorectal adenomas in an endoscopy-based population. Int. J. Cancer 2008, 122:1842-1848.
36. Traver R.D., et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res. 1992, 52:797-802.
37. Traver R.D., et al. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Br. J. Cancer 1997, 75:69-75.
38. Tsoi K.K., Pau C.Y., Wu W.K., Chan F.K., Griffiths S., Sung J.J. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin. Gastroenterol. Hepatol. 2009, 7(682-688):e681-e685.
39. van der Logt E.M., et al. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat. Res. 2006, 593:39-49.
40. Verla-Tebit E., Lilla C., Hoffmeister M., Brenner H., Chang-Claude J. Exposure to environmental tobacco smoke and the risk of colorectal cancer in a case-control study from Germany. Eur. J. Cancer Prev. 2009, 18:9-12.
41. Wan D.S. Epidemiologic trend of and strategies for colorectal cancer. Ai Zheng 2009, 28:897-902.
42. Wu Y., et al. The association of XPC polymorphisms and tea drinking with colorectal cancer risk in a Chinese population. Mol. Carcinog. 2011, 50:189-198.
43. Yang G., et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1219-1223.
44. Yu H., Liu H., Wang L.E., Wei Q. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS One 2012, 7:e30566.
45. Zheng Y., Wang J.J., Sun L., Li H.L. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol. Biol. Rep. 2012, 39:3533-3540.